PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA

Detalles Bibliográficos
Autores principales: Novosad, O., Pastushenko, I., Kadnikova, T., Tytorenko, I., Martynchyk, A., Gorbach, O., Ashyhmin, A., Kmetyuk, Y., Karpova, O., Mykhalska, L., Kindrakevych, O., Novikov, M., Oliinichenko, O., Kriachok, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431585/
http://dx.doi.org/10.1097/01.HS9.0000851092.94445.bd

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431585/
http://dx.doi.org/10.1097/01.HS9.0000851092.94445.bd

Ejemplares similares